BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7915270)

  • 1. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Wagner G
    J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
    Rabkin JG; Wagner GJ; Rabkin R
    Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant treatment of depression in HIV-seropositive women.
    Ferrando SJ; Rabkin JG; de Moore GM; Rabkin R
    J Clin Psychiatry; 1999 Nov; 60(11):741-6. PubMed ID: 10584761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Harrison W; Wagner G
    Am J Psychiatry; 1994 Apr; 151(4):516-23. PubMed ID: 7908501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of depression in HIV-infected patients.
    Cazzullo CL; Bessone E; Bertrando P; Pedrazzoli L; Cusini M
    J Psychiatry Neurosci; 1998 Nov; 23(5):293-7. PubMed ID: 9846034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine treatment of dysthymia in the elderly.
    Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
    J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine in the treatment of anger: an open clinical trial.
    Rubey RN; Johnson MR; Emmanuel N; Lydiard RB
    J Clin Psychiatry; 1996 Sep; 57(9):398-401. PubMed ID: 9746447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine efficacy in social phobia.
    Van Ameringen M; Mancini C; Streiner DL
    J Clin Psychiatry; 1993 Jan; 54(1):27-32. PubMed ID: 8428894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.
    Fabre LF; Scharf MB; Itil TM
    J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].
    Dalery J; Bouhassira M; Kress JP; Lancrenon S; Tafani A; Hantouche EG
    Encephale; 1995; 21(3):217-25. PubMed ID: 7649072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
    Besançon G; Cousin R; Guitton B; Lavergne F
    Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
    Dunlop SR; Dornseif BE; Wernicke JF; Potvin JH
    Psychopharmacol Bull; 1990; 26(2):173-80. PubMed ID: 2236453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in the context of human immunodeficiency virus infection: implications for treatment.
    Hintz S; Kuck J; Peterkin JJ; Volk DM; Zisook S
    J Clin Psychiatry; 1990 Dec; 51(12):497-501. PubMed ID: 2258363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.